Compounds > fluorouracil

fluorouracil and tivozanib

fluorouracil has been researched along with tivozanib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotreau, MM; de Vries, EG; den Hollander, MW; Eskens, FA; Esteves, B; Gietema, JA; Loos, WJ; Oldenhuis, CN; Strahs, AL; van Doorn, L1
Ball, HA; Benson, AB; Bridgewater, J; Chen, J; Eskens, FA; Keating, A; Kiss, I; Krivoshik, A; Sasse, C; Van Sant, C; Vossen, S1

Trials

2 trial(s) available for fluorouracil and tivozanib

ArticleYear
A phase Ib study of the VEGF receptor tyrosine kinase inhibitor tivozanib and modified FOLFOX-6 in patients with advanced gastrointestinal malignancies.
    Clinical colorectal cancer, 2015, Volume: 14, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Phenylurea Compounds; Quinolines; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome

2015
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Oct-15, Volume: 22, Issue:20

    Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neuropilin-1; Organoplatinum Compounds; Phenylurea Compounds; Quinolines; Receptors, Vascular Endothelial Growth Factor

2016